RECRUITING

Impact of AI on Trainee ADR

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Adenoma detection rate (ADR) is a validated quality metric for colonoscopy with higher ADR correlated with improved colorectal cancer outcomes. Artificial intelligence (AI) can automatically detect polyps on the video monitor which may allow endoscopists in training to improve their ADR. Objective and Purpose of the study: Measure the effect of AI in a prospective, randomized manner to determine its impact on ADR of Gastroenterology trainees.

Official Title

Impact of Artificial Intelligence on Trainee Adenoma Detection Rate

Quick Facts

Study Start:2023-01-01
Study Completion:2025-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05423964

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * All Gastroenterology fellows at USC performing Endoscopies will be included in the study.
  1. * If fellows refuse informed consent they will be excluded.
  2. * Procedures performed in the intensive care unit or the operating room will not be counted toward the study metrics as the AI system will only be available in the endoscopy unit.
  3. * If procedures are performed only by faculty, in which the fellow is not the primary operator, they will not be used for study metrics.

Contacts and Locations

Study Contact

Jessica Serna, BS
CONTACT
323-409-6939
Jessica.Serna@med.usce.edu
Alex Rodriguez, BS
CONTACT
323-409-6939
Alex.Rodriguez@med.usc.edu

Principal Investigator

James L Buxbaum, MD
PRINCIPAL_INVESTIGATOR
University of Southern California

Study Locations (Sites)

LAC+USC Medical Center
Los Angeles, California, 90033
United States

Collaborators and Investigators

Sponsor: University of Southern California

  • James L Buxbaum, MD, PRINCIPAL_INVESTIGATOR, University of Southern California

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-01-01
Study Completion Date2025-09

Study Record Updates

Study Start Date2023-01-01
Study Completion Date2025-09

Terms related to this study

Additional Relevant MeSH Terms

  • Adenoma
  • Adenoma Colon
  • Colorectal Cancer